Jim Horhey

PHD Doctor of Philosophy,  Mayo Clinic - Rochester 

Location: Germany

Consulting Services

IT-Web-Mobile Technology Case Consulting

Areas Of Interest

Carotid Thrombosis Membrane, Inner Mitochondrial Chlorpiprazine Treatment, Tocolytic Tests, Direct Antiglobulin Translational Initiation, Protein Dibrom Orbital Neoplasm Wiskott-Aldrich Syndrome Protein Family Voltage Dependent, Anion Selective Channels Vertebral Artery Dissection, Spontaneous Metabonomic Multi Vesicular Bodies Auricular Surface of Ilium Instruction Headache Tema, Norkotral Nodular Lymphocyte-Predominant Hodgkin's Lymphoma Calcium Activated Neutral Protease Rhythms, Nycthemeral Ventriculo peritoneal Shunt Addiction, Opium Coriander Thrombophlebitides, Petrous Sinus Immunoblastic Lymphosarcoma, Diffuse Johns Wort, St. Pleuroscopies gamma-Melanocyte-Stimulating Hormone v-sis, Oncogene Proteins Corticotropin (1-24)-Peptide Macedonia, Republic PEBP2A Transcription Factors Inlyta Vision Deficiency, Color Thalassemia Minor (beta Thalassemia Minor) Sulfate Transporters Detection, Substance Abuse Congenital Ectodermal Defects

Professional Narrative

Dr. Jim Horhey was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Horhey has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.

Employment

Senior Director, Mayo Clinic 1997
Executive Director, Harvard Med 2009

Education

Doctor of medicine, Harvard Medical School 2019
Master of Science in physician assistant, Harvard Medical School 1990

Referees

Publications

Platt RJ, Chen S, Zhou Y, Yim MJ, Swiech L, Kempton HR, Dahlman JE, Parnas O, Eisenhaure TM, Jovanovic M, Graham DB, Jhunjhunwala S, Heidenreich M, Xavier RJ, Langer R, Anderson DG, Hacohen N, Regev A, Feng G, Sharp PA, Zhang F. CRISPR- Cas9 knockin mice for genome editing and cancer modeling. Cell. 2014 Oct 9;159(2):440-55. doi: 10.1016/j.cell.2014.09.014. Epub 2014 Sep 25. PMID: 25263330; PMCID: PMC4265475.

Gupta A, Andresen JL, Manan RS, Langer R. Nucleic acid delivery for therapeutic applications. Adv Drug Deliv Rev. 2021 Nov;178:113834. doi: 10.1016/j.addr.2021.113834. Epub 2021 Sep 4. PMID: 34492233.

Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847-860. doi: 10.1038/s41578-020-00247-y. Epub 2020 Oct 14. PMID: 33078077; PMCID: PMC7556605.

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.

Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :

Languages

Language Proficiency :

Translation Services :

Serving Millions of physicians and biomedical scientists in Industry and academia.

Site
Services
Follow Us
Contact Us
  • support@scienceandminds.com

Copyright © 2025 Trialect Inc. All rights reserved. | v2023.06.17.02